About Us

Investment Management Team
Board of Directors
Fund Manager
Key Facts
How to Invest

The Investment Management Team

The investment management team has a breadth of experience and knowledge across both public and private investments in the biotechnology and healthcare sectors.

The majority of the Trust's investments made are in public markets and are managed by Ailsa Craig and Marek Poszepczynski. Private or venture capital investments are made via a venture fund, currently SV Fund VI, under the guidance of the SV core Biotech team co-led by Kate Bingham and Houman Ashrafian.

Board of Directors

The Board determines and monitors the Trust's investment objective and policy, and considers its future strategic direction: being collectively responsible for the long-term success of the Trust.

They meet formally five times a year, but also meet informally on other occasions, as required. As is appropriate, they have delegated various functions to other parties, the performance of which are regularly reviewed.

The Alternative Investment Fund Manager

SV Health Managers is a specialist healthcare fund manager investing across multiple stages and sectors. SV manages healthcare private equity and venture funds as well as, in the public equities space, International Biotechnology Trust. International Biotechnology Trust benefits from an investment in one of SV’s venture funds, as well as being able to draw on the extensive expertise of SV’s specialist investment team across all four of its focus areas. These focus areas are Biotechnology, Dementia, Healthcare Growth and Medtech.

Key Facts

International Biotechnology Trust Details

Inception Date
6th May 1994
Year End
31st August
Results Announced
Late October / Early November
Next AGM
December
Management Fee
0.9% NAV
Performance Fee
10% of quoted portfolio NBI (£) outperformance plus a 0.5% hurdle
20% of net gains made from unquoted investments
See page 26 of the Annual Report
Continuation vote
At AGM in 2023; every two years
Dividend
4% of NAV p.a. bi-annually - please see dividend policy for more details
Dividend Payment Dates
January and August each year
Ex Dividend Dates
December and July each year
Next Ex Dividend Date
July 2023
Listed
London Stock Exchange
ISIN
GB0004559349
SEDOL
0455934 GB
Reuters
IBT.L
Bloomberg
IBT LN
Issued Share Capital at 31 December 2022
40,764,829 (excluding 618,988 shares in treasury)

The Alternative Investment Fund Manager

Key Facts

International Biotechnology Trust Details

Disclaimer